Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Organovo Holdings Inc (NYSE MKT LLC:ONVO)

4.06
Delayed Data
As of Jul 22
 +0.04 / +1.00%
Today’s Change
1.60
Today|||52-Week Range
4.35
+63.05%
Year-to-Date
Why Organovo's Latest Publication Could Be Big News
Jul 12 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close4.02
Today’s open4.05
Day’s range4.01 - 4.14
Volume450,401
Average volume (3 months)776,127
Market cap$375.1M
Dividend yield--
Data as of 4:02pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-13.16%
Earnings growth (this year)+1.16%
Earnings growth (next 5 years)--
Revenue growth (last year)+159.72%
P/E ratioNM
Price/Sales131.78
Price/Book6.03

Competitors

 Today’s
change
Today’s
% change
NDRMNeuroderm Ltd-0.23-1.30%
VYGRVoyager Therapeutics...+1.20+9.48%
AGENAgenus Inc+0.13+2.80%
CGENCompugen Ltd-0.01-0.15%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$1.5M
Annual profit (last year)-$38.6M
Net profit margin-2,601.15%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Keith Murphy
Chief Scientific Officer
Sharon Collins Presnell
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs